Literature DB >> 25585787

Differential motion between mediastinal lymph nodes and primary tumor in radically irradiated lung cancer patients.

Eva E Schaake1, Maddalena M G Rossi2, Wieneke A Buikhuisen3, Jacobus A Burgers3, Adrianus A J Smit4, José S A Belderbos2, Jan-Jakob Sonke5.   

Abstract

PURPOSE/
OBJECTIVE: In patients with locally advanced lung cancer, planning target volume margins for mediastinal lymph nodes and tumor after a correction protocol based on bony anatomy registration typically range from 1 to 1.5 cm. Detailed information about lymph node motion variability and differential motion with the primary tumor, however, is lacking from large series. In this study, lymph node and tumor position variability were analyzed in detail and correlated to the main carina to evaluate possible margin reduction. METHODS AND MATERIALS: Small gold fiducial markers (0.35 × 5 mm) were placed in the mediastinal lymph nodes of 51 patients with non-small cell lung cancer during routine diagnostic esophageal or bronchial endoscopic ultrasonography. Four-dimensional (4D) planning computed tomographic (CT) and daily 4D cone beam (CB) CT scans were acquired before and during radical radiation therapy (66 Gy in 24 fractions). Each CBCT was registered in 3-dimensions (bony anatomy) and 4D (tumor, marker, and carina) to the planning CT scan. Subsequently, systematic and random residual misalignments of the time-averaged lymph node and tumor position relative to the bony anatomy and carina were determined. Additionally, tumor and lymph node respiratory amplitude variability was quantified. Finally, required margins were quantified by use of a recipe for dual targets.
RESULTS: Relative to the bony anatomy, systematic and random errors ranged from 0.16 to 0.32 cm for the markers and from 0.15 to 0.33 cm for the tumor, but despite similar ranges there was limited correlation (0.17-0.71) owing to differential motion. A large variability in lymph node amplitude between patients was observed, with an average motion of 0.56 cm in the cranial-caudal direction. Margins could be reduced by 10% (left-right), 27% (cranial-caudal), and 10% (anteroposterior) for the lymph nodes and -2%, 15%, and 7% for the tumor if an online carina registration protocol replaced a protocol based on bony anatomy registration.
CONCLUSIONS: Detailed analysis revealed considerable lymph node position variability, differential motion, and respiratory motion. Planning target volume margins can be reduced up to 27% in lung cancer patients when the carina registration replaces bony anatomy registration.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25585787     DOI: 10.1016/j.ijrobp.2014.07.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy.

Authors:  Matthew P Deek; Sinae Kim; Ning Yue; Rekha Baby; Inaya Ahmed; Wei Zou; John Langenfeld; Joseph Aisner; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Asymmetric margin setting at the cranial and caudal sides in respiratory gated and non-gated stereotactic body radiotherapy for lung cancer.

Authors:  Yoshihiro Ueda; Shingo Oohira; Masaru Isono; Masayoshi Miyazaki; Teruki Teshima
Journal:  Br J Radiol       Date:  2015-12-23       Impact factor: 3.039

Review 3.  Magnetic resonance imaging in precision radiation therapy for lung cancer.

Authors:  Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 4.  Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer.

Authors:  Jason K Molitoris; Tejan Diwanji; James W Snider; Sina Mossahebi; Santanu Samanta; Shahed N Badiyan; Charles B Simone; Pranshu Mohindra
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  Motion-compensated FDG PET/CT for oesophageal cancer.

Authors:  Francine E M Voncken; Erik Vegt; Johanna W van Sandick; Jolanda M van Dieren; Cecile Grootscholten; Annemarieke Bartels-Rutten; Steven L Takken; Jan-Jakob Sonke; Jeroen B van de Kamer; Berthe M P Aleman
Journal:  Strahlenther Onkol       Date:  2021-04-07       Impact factor: 3.621

Review 6.  Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review.

Authors:  Dirk De Ruysscher; Edmond Sterpin; Karin Haustermans; Tom Depuydt
Journal:  Cancers (Basel)       Date:  2015-06-29       Impact factor: 6.639

7.  Deep inspiration breath hold in locally advanced lung cancer radiotherapy: validation of intrafractional geometric uncertainties in the INHALE trial.

Authors:  Mirjana Josipovic; Marianne C Aznar; Jakob B Thomsen; Jonas Scherman; Sidsel Ms Damkjaer; Lotte Nygård; Lena Specht; Mette Pøhl; Gitte F Persson
Journal:  Br J Radiol       Date:  2019-09-26       Impact factor: 3.039

8.  Image-guidance triggered adaptive replanning of radiation therapy for locally advanced lung cancer: an evaluation of cases requiring plan adaptation.

Authors:  Sarit Appel; Jair Bar; Dror Alezra; Maoz Ben-Ayun; Tatiana Rabin-Alezra; Nir Honig; Tamar Katzman; Sumit Chatterji; Zvi Symon; Yaacov Richard Lawrence
Journal:  Br J Radiol       Date:  2019-11-13       Impact factor: 3.039

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.